Company news

Active Biotech AB news in 2025

Active Biotech AB's news releases, calls and decks from 2025, newest first.

View company

Active Biotech announces outcome in the rights issue

December 10, 2025

Active Biotech’s patent related to a pharmaceutical formulation of tasquinimod will be granted in the US

November 25, 2025

Active Biotech publishes information document regarding rights issue

November 20, 2025

Extraordinary General Meeting of Active Biotech AB

November 19, 2025

Active Biotech Interim Report Q3 2025

November 6, 2025

Decks in 2025